This video shows a scientist explaining and discussing CRISPR to people of 5 different levels of expertise from a 7-year old to an expert in CRISPR technology. Stick with it, it keeps getting better.
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.